Literature DB >> 3048334

Interaction of tumor cells and immune system in the metastatic process.

E Gorelik1, Y Gunji, R H Goldfarb.   

Abstract

The metastatic process is rather complicated and relatively inefficient. Millions of tumor cells are constantly shedding from the primary tumor into the blood stream, but very few of them are able to form metastatic tumors in the different organs or tissues of the host. It is widely accepted that metastatic cells have to possess a complex array of various properties that allow them to complete the metastatic cascade. The realization of the metastatic potential largely depends on the ability of tumor cells to evade host defense mechanisms. The potential role of specific and nonspecific immune mechanisms in the control of metastatic spread and growth is the subject of the present review. A better understanding of the mechanisms of antimetastatic defense is of prime importance for development of efficient immunotherapeutic methods for the treatment and eradication of disseminated tumor metastases.

Entities:  

Mesh:

Year:  1988        PMID: 3048334     DOI: 10.1139/o88-071

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  3 in total

1.  Natural killer sensitivity of tumor cells isolated from primary and metastatic lesions of four Bomirski melanoma variants.

Authors:  J Bigda; A Myśliwski; D Sosnowska; P Romanowski; A Bomirski
Journal:  Clin Exp Metastasis       Date:  1991 Jan-Feb       Impact factor: 5.150

2.  Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL).

Authors:  L Tentori; C Leonetti; F Lozupone; E Bonmassar
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

Review 3.  Mononuclear phagocytes in head and neck squamous cell carcinoma.

Authors:  Kenneth Wilfried Kross; John-Helge Heimdal; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-05       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.